Genprex Inc (GNPX)

Official site

HEALTHCARE • BIOTECHNOLOGY • NASDAQ

$2.29

-0.04 (-1.72%)

Market Cap: $1.91M

Last updated: Oct 16, 2026 at 1:55 PM ET

Earnings

Performance (10Y)

Beat Rate

40%(12/30)

Avg Surprise

-328.97%

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Jun 30, 2026Jun 26 Reported Aug 14, 2026Reported Aug 14	$-9.40	N/A	-	N/A	Beat	-	-	-11.0%
Mar 31, 2026Mar 26 Reported May 13, 2026Reported May 13	$-14.12	N/A	-	N/A	Beat	-	-	-647.3%
Dec 31, 2025Dec 25 Reported Mar 30, 2026Reported Mar 30	$-25.33	$0.83	$0.83 - $0.83	-3152.22%	Miss	0	1 0 30d	-5872.0%
Sep 30, 2025Sep 25 Reported Nov 14, 2025Reported Nov 14	$-5.00	$-0.65	$-0.65 - $-0.65	-669.23%	Miss	0	1 0 30d	+99.6%
Jun 30, 2025Jun 25 Reported Aug 14, 2025Reported Aug 14	$-8.47	$-0.74	$-0.74 - $-0.74	-1044.59%	Miss	1	1 0 30d	+99.7%
Mar 31, 2025Mar 25 Reported Apr 7, 2025Reported Apr 7	$2.58	$-0.39	$-0.39 - $-0.39	+761.54%	Beat	1	1 0 30d	+100.1%
Dec 31, 2024Dec 24 Reported Mar 31, 2025Reported Mar 31	$-0.42	$-0.39	$-0.39 - $-0.39	-8.77%	Miss	1	1 0 30d	+89.3%
Sep 30, 2024Sep 24 Reported Nov 13, 2024Reported Nov 13	$-1353.00	N/A	-	+54.95%	Beat	2	No revisions (30d)	-1040669.2%
Jun 30, 2024Jun 24 Reported Aug 9, 2024Reported Aug 9	$-3300.00	$-2530.00	$-2530.00 - $-2530.00	-30.43%	Miss	1	No revisions (30d)	-2199900.0%
Mar 31, 2024Mar 24 Reported May 15, 2024Reported May 15	$-4059.00	$-2794.00	$-2794.00 - $-2794.00	-45.28%	Miss	1	No revisions (30d)	-2136215.8%
Dec 31, 2023Dec 23 Reported Mar 29, 2024Reported Mar 29	$-3.96	$-3.93	$-5.60 - $-0.80	-0.76%	Miss	3	No revisions (30d)	+99.9%
Sep 30, 2023Sep 23 Reported Nov 14, 2023Reported Nov 14	$-0.13	$-0.11	$-0.11 - $-0.11	-18.18%	Miss	1	No revisions (30d)	+100.0%
Jun 30, 2023Jun 23 Reported Aug 21, 2023Reported Aug 21	$-0.15	$-0.12	$-0.12 - $-0.12	-25.00%	Miss	1	No revisions (30d)	+100.0%
Mar 31, 2023Mar 23 Reported May 22, 2023Reported May 22	$-0.19	$-0.12	$-0.12 - $-0.12	-58.33%	Miss	1	No revisions (30d)	+100.0%
Dec 31, 2022Dec 22 Reported Mar 31, 2023Reported Mar 31	$-6600.01	$-6600.01	$-6600.02 - $-6600.00	+0.00%	Beat	2	No revisions (30d)	-5499908.3%
Sep 30, 2022Sep 22 Reported Nov 14, 2022Reported Nov 14	$-5720.01	$-5280.01	$-5280.01 - $-5280.01	-8.33%	Miss	1	No revisions (30d)	-85.7%
Jun 30, 2022Jun 22 Reported Aug 12, 2022Reported Aug 12	$-4840.00	$-5280.01	$-5280.01 - $-5280.01	+8.33%	Beat	1	No revisions (30d)	-37.5%
Mar 31, 2022Mar 22 Reported May 13, 2022Reported May 13	$-5280.01	$-5280.01	$-5280.01 - $-5280.01	+0.00%	Beat	1	No revisions (30d)	+14.3%
Dec 31, 2021Dec 21 Reported Mar 30, 2022Reported Mar 30	$-0.12	$-0.09	$-0.11 - $-0.08	-33.33%	Miss	2	No revisions (30d)	+14.3%
Sep 30, 2021Sep 21 Reported Nov 15, 2021Reported Nov 15	$-3080.00	$-4840.00	$-4840.00 - $-4840.00	+36.36%	Beat	0	No revisions (30d)	+0.0%
Jun 30, 2021Jun 21 Reported Aug 13, 2021Reported Aug 13	$-3520.00	$-5720.01	$-5720.01 - $-5720.01	+38.46%	Beat	1	No revisions (30d)	+33.3%
Mar 31, 2021Mar 21 Reported May 17, 2021Reported May 17	$-6160.01	$-5280.01	$-5280.01 - $-5280.01	-16.67%	Miss	1	No revisions (30d)	+30.0%
Dec 31, 2020Dec 20 Reported Mar 26, 2021Reported Mar 26	$-0.14	$-0.28	$-0.28 - $-0.28	+50.00%	Beat	1	No revisions (30d)	+6.7%
Sep 30, 2020Sep 20 Reported Nov 12, 2020Reported Nov 12	$-3080.00	N/A	-	+66.67%	Beat	1	No revisions (30d)	-1283233.3%
Jun 30, 2020Jun 20 Reported Aug 11, 2020Reported Aug 11	$-5280.01	$-8360.01	$-8360.07 - $-8359.95	+36.84%	Beat	2	No revisions (30d)	+14.3%
Mar 31, 2020Mar 20 Reported May 14, 2020Reported May 14	$-8800.01	$-3520.00	-	-150.00%	Miss	-	-	-109900.1%
Sep 30, 2019Sep 19 Reported Nov 14, 2019Reported Nov 14	$-0.15	$-0.22	$-0.22 - $-0.22	+31.82%	Beat	0	No revisions (30d)	+100.0%
Jun 30, 2019Jun 19 Reported Aug 13, 2019Reported Aug 13	$-0.24	$-0.21	$-0.21 - $-0.21	-14.29%	Miss	1	No revisions (30d)	+22.6%
Mar 31, 2019Mar 19 Reported Apr 1, 2019Reported Apr 1	$-6160.01	$-9240.01	$-9240.04 - $-9239.98	+33.33%	Beat	3	No revisions (30d)	-12319920.0%
Dec 31, 2018Dec 18 Reported Mar 29, 2019Reported Mar 29	$-8.00	$-0.14	$-0.15 - $-0.12	-5614.29%	Miss	2	No revisions (30d)	-11328.6%
Sep 30, 2018Sep 18 Reported Nov 14, 2018Reported Nov 14	$-6600.01	$-5720.01	$-5720.01 - $-5720.01	-15.38%	Miss	0	No revisions (30d)	-13199920.0%
Jun 30, 2018Jun 18 Reported Aug 14, 2018Reported Aug 14	$-0.31	$-0.17	-	-82.35%	Miss	-	-	-
Mar 31, 2018Mar 18 Reported May 15, 2018Reported May 15	$-0.05	N/A	-	N/A	Beat	-	-	-
Sep 30, 2017Sep 17 Reported Nov 27, 2017Reported Nov 27	$-0.07	$0.00	-	N/A	Miss	-	-	-
Jun 30, 2017Jun 17 Reported Jul 21, 2017Reported Jul 21	$-0.05	$0.00	-	N/A	Miss	-	-	-

Key Metrics

Valuation
P/E Ratio	-0.04	EV/EBITDA	N/A
Price/FCF	N/A	FCF Yield	N/A
Profitability
Profit Margin	0.00%	Operating Margin	0.00%
ROE	-203.90%	ROIC	N/A
Financial Health
Debt/Equity	0.00x	Interest Coverage	N/A
Current Ratio	6.77x	Quick Ratio	6.77x
Trading Statistics
Beta	-0.97	Avg Volume	287.74K
52-Week High	$455.40	52-Week Low	$2.30

Technical Indicators Dashboard

Moving Averages

SMA 10$2.59

SMA 20$2.90

SMA 50$3.48

SMA 200$22.84

EMA 10$2.59

EMA 20$2.85

EMA 50$4.34

EMA 200$39.87

MACD

Line: -0.39Signal: -0.41Hist: 0.02

ADX

ADX: 10.0+DI: 12.4-DI: 19.2

Aroon & PSAR

Aroon Up36.0

Aroon Down100.0

PSAR$3.25

Bollinger Bands

Upper Band$3.78

Lower Band$2.03

%B Position6041%(Upper)

Band Width0.15

RSI (14-Day)

Oversold

26.7

Momentum Oscillators

Stoch %K2.9

Stoch %D4.6

Williams %R-93.7

ROC (10d)-10.5%

Momentum-0.27

CCI (20d)-115.6

MFI (14d)33.6

Volatility Measures

ATR (14d)$0.38(16.5%)

StdDev (20d)0.44

Hist Vol87.9%(High)

Volume Flow

VWAP$2.31

OBV868.2M

AD Line11791.1B

CMF (20d)-0.295

Volume Metrics

Avg Vol (20d)311.4K

Vol Ratio0.7x

VWMA (20d)$3.18

Pivot Points

R3$2.74

R2$2.64

R1$2.49

Pivot Point$2.39

S1$2.24

S2$2.14

S3$1.99

Advanced Oscillators

TSI-39.58

Ultimate Osc29.7

KST-271.49

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$-2,208	$0
Cost of Revenue	$0	$0	N/A	$0	$0	$0	N/A	$0	$0	$0	N/A	$0
Gross Profit	$0	$0	N/A	$0	$0	$0	N/A	$0	$0	$0	$-2,208	$0

Operating Expenses	$4.48M	$4.49M	$3.52M	$3.35M	$4.68M	$3.97M	$4.34M	$4.32M	$6.52M	$6.00M	$5.97M	$7.79M
R&D	$2.68M	$2.75M	$2.20M	$2.19M	$2.50M	$2.54M	$2.84M	$2.76M	$1.67M	$3.27M	$3.71M	$4.62M
SG&A	$1.80M	$1.75M	$1.32M	$1.15M	$2.18M	$1.43M	$1.50M	$1.57M	$4.85M	$2.72M	$2.25M	$3.17M
Operating Income	$-4,483,984	$-4,494,184	$-3,518,630	$-3,345,913	$-4,681,784	$-3,969,292	$-4,335,730	$-4,323,438	$-6,518,282	$-5,996,717	$-5,968,062	$-7,786,327

Interest Income	$-525	$0	$0	$2,405	$2	$0	$0	$8,080	$23,057	$27,713	$39,697	$51,391
Interest Expense	$525	$0	$298,481	$453,327	$0	$80	$57,736	$0	$0	$0	$0	$0
Income Before Tax	$-4,484,509	$-4,493,643	$-3,817,111	$-3,799,240	$-4,681,782	$-3,969,372	$-4,393,466	$-4,315,987	$-6,495,845	$-5,968,869	$-5,927,043	$-7,748,243
Income Tax Expense	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0

Net Income	$-4,447,219	$-4,461,895	$-3,790,211	$-3,799,240	$-4,674,901	$-3,964,601	$-4,330,462	$-4,315,987	$-6,495,845	$-5,968,869	$-5,929,251	$-7,748,243

EBITDA	$-4,483,984	$-4,493,643	$-3,803,054	$-3,801,645	$-4,681,784	$-3,969,372	$-4,334,153	$-4,322,795	$-6,516,614	$-5,993,912	$-5,964,636	$-7,795,909
EBIT	$-4,483,984	$-4,493,643	$-3,803,054	$-3,801,645	$-4,681,784	$-3,969,372	$-4,334,616	$-4,324,067	$-6,518,902	$-5,996,582	$-5,968,062	$-7,799,634

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about GNPX

News

Genprex Inc (GNPX-Q) Stock Price and News

This article provides stock information and recent news for Genprex Inc. (GNPX-Q), a biotechnology company focused on immunogene therapies for cancer and gene therapies for diabetes. The news highlights the company's...

The Globe and Mail•Oct 1, 2026 1:55 PM ET10/1/26•Somewhat-Bullish

Genprex, Inc. Revenue Breakdown – NASDAQ:GNPX

This article provides a revenue breakdown for Genprex, Inc. (NASDAQ: GNPX) as found on TradingView. It highlights the availability of financial data, including statements, statistics, dividends, earnings...

TradingView•Oct 1, 2026 5:10 AM ET10/1/26•Neutral

Form 8K Genprex Inc For: 18 August By Investing.com

This article announces that Genprex Inc. filed a Form 8K on August 18, 2026. The filing is brief and primarily serves as a notification of the SEC document's availability...

Investing.com South Africa•Aug 18, 2026 8:11 AM ET8/18/26•Neutral

Genprex is scaling a diabetes therapy designed to deliver two genes to the pancreas

Genprex has partnered with a leading U.S.-based Contract Development and Manufacturing Organization (CDMO) to scale up manufacturing of its AAV-based diabetes gene therapy. This collaboration aims to transition...

Stock Titan•Aug 18, 2026 7:11 AM ET8/18/26•Somewhat-Bearish

Genprex partners with CDMO for diabetes gene therapy manufacturing

Genprex Inc. announced a partnership with a U.S.-based contract development and manufacturing organization (CDMO) to scale up production of its diabetes gene therapy program. This collaboration aims to transition...

Investing.com•Aug 18, 2026 7:11 AM ET8/18/26•Bullish

GNPX Valuation and Fair Value

P/E: -0.0x
P/B: 0.1x

See GNG's fair value

GNPX Profitability: Margins, ROIC and FCF

Operating margin: 0.0%
Net margin: 0.0%
ROE: -203.9%

GNPX Competitors

Company	Ticker
Nexgel Inc	NXGL
Oragenics Inc	OGEN
Purple Biotech	PPBT
Curis Inc	CRIS
NewGenIvf Group Limited Class A Ordinary Shares	NIVF
Protagenic Therapeutics	PTIX
Beyond Air Inc	XAIR
Iterum Therapeutics PLC	ITRM

Sector: Healthcare

GNPX Bull Case vs Bear Case

Bear case

GNPX beat EPS estimates in 25.0% of its last 8 reported quarters.

GNPX Earnings: Beat Rate and Next Report

Beat rate: 2 of 8 quarters (25.0%)
Average surprise: -140.3%

Frequently Asked Questions About GNPX

Does GNPX pay dividends?

Genprex Inc (GNPX) does not currently pay a regular dividend.

What is GNPX's market cap?

Genprex Inc (GNPX) has a market capitalization of $1.91M with a current stock price of $2.29.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In